ARTICLES / JUNE 30, 2026
In March 2026, a California jury ordered Meta and YouTube to pay $6 million to a plaintiff who alleged that childhood use of social media platforms contributed to addiction, anxiety, depression, and other mental health harms.
For companies of the defendants’ size, $6 million in damages will not have a material effect. What matters is that a jury was willing to credit a theory of liability that focuses less on content and more on how platforms are designed to drive engagement.
For insurance buyers, that distinction matters.
A familiar playbook
The legal strategy behind social media addiction litigation is not new. It borrows from arguments perfected in tobacco litigation and later applied to opioid manufacturers, distributors, and pharmacies.
The basic theory is straightforward: Companies allegedly knew their products could be addictive or harmful, failed to adequately warn users, and continued to design and promote those products in ways that increased use among vulnerable populations, particularly children and adolescents.
Cases like these often turn on what companies knew, when they knew it, and how they responded. Internal communications, product roadmaps, engagement dashboards, and safety reviews are not just business records; they are potential evidence.
The path forward also looks familiar. Opioid litigation began with manufacturers and later expanded across the supply chain. Social media litigation could follow a similar arc.
Major platforms are the most obvious targets because of their scale and visibility. But once a theory gains traction, plaintiffs' lawyers will likely set their sights on gaming companies, streaming platforms, app developers, and device manufacturers that rely on engagement mechanics or youth-focused design.
Companies that license, white label, or distribute third-party engagement technologies may also face exposure and should not assume they are insulated simply because they did not build the tools.
AI technologies are attracting litigation along similar lines. In June, Florida’s attorney general announced a lawsuit against OpenAI, the developer of generative AI platform ChatGPT (opens a new window), alleging that it “knowingly released and aggressively marketed ChatGPT to the public—including to children—while concealing serious risks, suppressing internal safety warnings, and deceiving Floridians about the true nature and dangers of the product.”
What is being alleged?
Potential targets must understand the shift from harmful content claims to product design claims, and how that shift affects both liability theories and insurance coverage.
In the Meta/YouTube suit, plaintiffs alleged that platforms knowingly incorporated features such as infinite scroll, autoplay, push notifications, and algorithmic recommendations to create defective or unreasonably dangerous products for minors.
This shift matters because it changes the scope of Section 230 protection. While Section 230 has historically shielded claims tied to third-party content, courts have been more willing to allow claims to proceed when they focus on platform design, safety controls, or business practices. That shift has a direct implication for this exposure because Section 230 may no longer fully limit litigation exposure.
Current litigation efforts involve multiple overlapping theories, including defective design, failure to warn, concealment of known mental health risks, deceptive practices, and public nuisance. This is not a single case or isolated exposure — it is an expanding litigation framework resembling tobacco, opioids, and asbestos.
For insurers and insureds, the exposure is difficult to model with traditional tools. The combination of personal injury claims and government actions creates a potentially long and uncertain financial tail.
Coverage considerations
For insurers writing general liability (GL), umbrella and excess casualty, directors and officers liability (D&O), technology errors and omissions (E&O), media liability, and cyber insurance coverage , the questions are complicated and form-specific, with few clear answers.
Bodily injury trigger
Alleged injuries often include anxiety, depression, eating disorders, sleep disruption, and self-harm. Whether these qualify as “bodily injury” depends on policy wording and jurisdiction.
Policies requiring physical injury or physical manifestation may respond differently than those that explicitly include mental anguish or emotional distress, leading to inconsistent outcomes.
Occurrence versus expected or intended injury
This may become one of the most consequential issues. Courts are increasingly examining whether intentional design decisions can be characterized as “accidental.” Coverage rulings involving social media addiction claims have focused heavily on whether intentional platform design choices can be treated as accidents under occurrence-based policies. For example, in Lemmon v. Snap, Inc. the 9th U.S. Circuit Court of Appeals allowed claims to proceed where a platform’s design features are central to the alleged harm.
As allegations focus on deliberate design choices and internal knowledge, it may become more difficult to treat resulting harm as accidental under occurrence-based policies.
Personal and advertising injury
Some complaints include allegations of misrepresentation or deceptive marketing, raising personal and advertising injury issues.
These claims may also trigger exclusions for knowing falsity, intentional acts, statutory violations, or unfair business practices.
Exclusions
Key exclusions include expected or intended injury, fraud, willful misconduct, statutory violations, consumer protection, fines and penalties, restitution, and disgorgement.
A central challenge is how and when these exclusions apply in multitheory litigation—and whether multiple exclusions may be triggered simultaneously across policies.
The same conduct could implicate GL, D&O, and E&O exclusions at once, potentially leaving meaningful gaps that no single policy was designed to address.
D&O coverage
D&O policies raise distinct issues. Conduct exclusions typically require a final, nonappealable adjudication, meaning defense costs are likely to drive early exposure.
Boards and senior leaders must also consider personal exposure: If internal documents show awareness of addiction risks, individual directors and officers may be named in litigation.
E&O, media, and cyber
Similar challenges are emerging across E&O, media, and cyber policies, particularly around professional services, content versus design, and conduct-based exclusions.
In many cases, early disputes will focus on defense obligations, especially in large, coordinated proceedings.
Allocation and aggregation
Claims spanning multiple years raise familiar long-tail questions:
When did injury occur?
How many policy years are implicated?
What constitutes a claim?
How should related claims be treated?
Batch clauses, related-claims provisions, and occurrence definitions will materially affect outcomes and may lead to disputes between insureds and insurers.
Aggregation also raises limits adequacy concerns. If thousands of claims are treated as a single occurrence, companies may find themselves significantly underinsured.
Look to the past
There are clear parallels between social media litigation and earlier tobacco and opioid cases, including contested liability, damaging internal documents, government involvement, and pressure toward large-scale resolution.
Social media litigation shares these features, but also presents unique challenges, including Section 230 considerations, First Amendment issues, the focus on children, and the complexity of proving causation for mental health outcomes.
Even with those differences, these cases have the potential to become high-severity litigation because they combine product design, youth harm, mental health, and corporate decision-making—an inherently difficult mix for juries.
The first jury verdict is unlikely to be the last. As appeals proceed and the law develops, early outcomes will influence settlement expectations, defense strategies, and perceptions of risk.
Taking action
Potential targets should not wait for further legal clarity before addressing this exposure. The following steps can help companies assess risk and strengthen their position:
Audit definitions and form language. Even small wording differences can lead to materially different outcomes. Confirm how bodily injury, personal injury, advertising injury, technology services, media liability, and wrongful acts are defined—and whether mental or behavioral health conditions are included or ambiguous.
Monitor litigation. Be prepared to disclose multidistrict litigation participation, coordinated proceedings, attorney general actions, and pre-suit notices. Companies in adjacent sectors—gaming, streaming, social applications—should prepare now rather than wait.
Review product design protocols. This is fundamentally a governance issue. Underwriters will expect insight into how companies address youth safety, age verification, engagement features, and product changes in response to risk.
Model defense costs realistically. Under D&O, E&O, media, and cyber programs, defense costs are likely to be a primary driver of exposure, especially in consolidated proceedings.
Pressure-test aggregation language. The distinction between one claim, many claims, one occurrence, or related wrongful acts can materially affect coverage outcomes.
Consider targeted endorsements. Standard forms were not built for addictive design litigation. Insureds and brokers should evaluate whether existing wording reflects intent.
Look beyond premium. This exposure requires a cross-functional approach that integrates insurance, governance, product design, and litigation strategy. Legal, product, engineering, finance, and communications functions all play a role in managing risk.
The first verdict is unlikely to be the last. As claims expand, social media addiction litigation is poised to test both liability and insurance frameworks.
Preparation will determine outcomes. Companies that act now to understand and manage their exposure will be better equipped for what comes next.

by Vince Gaffigan
EVP, Director, U.S. Market Strategy & Engagement